Shadow cost of oral corticosteroids-related adverse events: A pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry

BACKGROUND: Asthma is one of the most common non-communicable respiratory diseases, affecting about 6% of the general population. Severe asthma, even if afflicts a minority of asthmatics, drives the majority of costs of the disease. The aim of this study is to create a pharmacoeconomic model to pred...

Descripción completa

Detalles Bibliográficos
Autores principales: Canonica, Giorgio Walter, Colombo, Giorgio Lorenzo, Bruno, Giacomo Matteo, Di Matteo, Sergio, Martinotti, Chiara, Blasi, Francesco, Bucca, Caterina, Crimi, Nunzio, Paggiaro, Pierluigi, Pelaia, Girolamo, Passalaqua, Giovanni, Senna, Gianenrico, Heffler, Enrico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6439414/
https://www.ncbi.nlm.nih.gov/pubmed/30937132
http://dx.doi.org/10.1016/j.waojou.2018.12.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6439414/
https://www.ncbi.nlm.nih.gov/pubmed/30937132
http://dx.doi.org/10.1016/j.waojou.2018.12.001

Ejemplares similares